Article

Successful Identification and Treatment of Cancer of Unknown Primary Originating from Gastric Cancer Using Comprehensive Genomic Profiling and Immune Checkpoint Inhibitor Therapy

2024-11-26

Abstract excerpt

<h4>Background: </h4> Cancer of unknown primary (CUP) is a challenging malignancy characterized by metastatic tumors with an unidentified primary site, even after extensive pathological and radiographic evaluation. Recent advancements in gene expression profiling and comprehensive genomic profiling (CGP) using next-generation sequencing (NGS) have enabled the identification of potential tissue origins, thereby fac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9eff2351-26ed-533b-8e6c-55f237313188
DOI: 10.22541/au.173262106.64419644/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Successful Identification and Treatment of Cancer of Unknown Primary Originating from Gastric Cancer Using Comprehensive Genomic Profiling and Immune Checkpoint Inhibitor TherapyDOI 10.22541/au.173262106.64419644/v1Read

Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.Semantic proximity Read

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.Semantic proximity Read

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.Semantic proximity Read

Molecular landscape and sub-classification of gastrointestinal cancers: a review of literatureSemantic proximity Read

Cancer of unknown primary.Semantic proximity Read

Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Semantic proximity Read

Real-world data analysis of patients with cancer of unknown primarySemantic proximity Read

Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.Semantic proximity Read

Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.Semantic proximity Read

Molecular driver alterations and their clinical relevance in cancer of unknown primary site.Semantic proximity Read

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.Semantic proximity Read

Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy.Semantic proximity Read